{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T03:00:59Z","timestamp":1790823659500,"version":"4.1.0"},"reference-count":107,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,4,9]],"date-time":"2019-04-09T00:00:00Z","timestamp":1554768000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","award":["15428"],"award-info":[{"award-number":["15428"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","award":["18274"],"award-info":[{"award-number":["18274"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","award":["19920"],"award-info":[{"award-number":["19920"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","award":["20312"],"award-info":[{"award-number":["20312"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","award":["21147"],"award-info":[{"award-number":["21147"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["V806A"],"award-info":[{"award-number":["V806A"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2019.00719","type":"journal-article","created":{"date-parts":[[2019,4,9]],"date-time":"2019-04-09T06:45:17Z","timestamp":1554792317000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":73,"title":["NKp44-NKp44 Ligand Interactions in the Regulation of Natural Killer Cells and Other Innate Lymphoid Cells in Humans"],"prefix":"10.3389","volume":"10","author":[{"given":"Monica","family":"Parodi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herman","family":"Favoreel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Candiano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Gaggero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Sivori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Cristina","family":"Mingari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Moretta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Vitale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Cantoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,4,9]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1126\/science.1198687","article-title":"Innate or adaptive immunity? The example of natural killer cells","volume":"331","author":"Vivier","year":"2011","journal-title":"Science."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/j.cell.2018.07.017","article-title":"Innate lymphoid cells: 10 years on","volume":"174","author":"Vivier","year":"2018","journal-title":"Cell."},{"key":"B3","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.imlet.2018.11.004","article-title":"Human natural killer cells and other innate lymphoid cells in cancer: Friends or foes?","volume":"201","author":"Vacca","year":"2018","journal-title":"Immunol Lett."},{"key":"B4","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1016\/j.immuni.2017.10.008","article-title":"The broad spectrum of human natural killer cell diversity","volume":"47","author":"Freud","year":"2017","journal-title":"Immunity."},{"key":"B5","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1038\/nri.2016.34","article-title":"Emerging insights into natural killer cells in human peripheral tissues. Nature reviews","volume":"16","author":"Bjorkstrom","year":"2016","journal-title":"Immunology."},{"key":"B6","doi-asserted-by":"publisher","first-page":"2324","DOI":"10.3389\/fimmu.2018.02324","article-title":"Molecular mechanisms directing migration and retention of natural killer cells in human tissues","volume":"9","author":"Castriconi","year":"2018","journal-title":"Front Immunol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/j.it.2018.04.009","article-title":"NK cells mediate a crucial graft-versus-leukemia effect in haploidentical-HSCT to cure high-risk acute leukemia","volume":"39","author":"Locatelli","year":"2018","journal-title":"Trends Immunol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1146\/annurev-immunol-020711-075005","article-title":"Controlling natural killer cell responses: integration of signals for activation and inhibition","volume":"31","author":"Long","year":"2013","journal-title":"Annu Rev Immunol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1038\/nri956","article-title":"Natural killer cells and dendritic cells: rendezvous in abused tissues. Nature reviews","volume":"2","author":"Moretta","year":"2002","journal-title":"Immunology."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.4049\/jimmunol.1102002","article-title":"Human NK cells induce neutrophil apoptosis via an NKp46- and Fas-dependent mechanism","volume":"188","author":"Thoren","year":"2012","journal-title":"J Immunol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"21659","DOI":"10.1073\/pnas.1007654108","article-title":"The interaction of human natural killer cells with either unpolarized or polarized macrophages results in different functional outcomes","volume":"107","author":"Bellora","year":"2010","journal-title":"Proc Natl Acad Sci USA."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1038\/ni1138","article-title":"Induced recruitment of NK cells to lymph nodes provides IFN-gamma for T(H)1 priming","volume":"5","author":"Martin-Fontecha","year":"2004","journal-title":"Nat Immunol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"4778","DOI":"10.1182\/blood-2010-08-300954","article-title":"DNAM-1 ligand expression on Ag-stimulated T lymphocytes is mediated by ROS-dependent activation of DNA-damage response: relevance for NK-T cell interaction","volume":"117","author":"Ardolino","year":"2011","journal-title":"Blood."},{"key":"B14","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1146\/annurev.immunol.19.1.197","article-title":"Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis","volume":"19","author":"Moretta","year":"2001","journal-title":"Annu Rev Immunol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"2065","DOI":"10.1084\/jem.187.12.2065","article-title":"NKp44, a novel triggering surface molecule specifically expressed by activated natural killer cells, is involved in non-major histocompatibility complex-restricted tumor cell lysis","volume":"187","author":"Vitale","year":"1998","journal-title":"J Exp Med."},{"key":"B16","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1084\/jem.189.5.787","article-title":"NKp44, a triggering receptor involved in tumor cell lysis by activated human natural killer cells, is a novel member of the immunoglobulin superfamily","volume":"189","author":"Cantoni","year":"1999","journal-title":"J Exp Med."},{"key":"B17","doi-asserted-by":"publisher","first-page":"69","DOI":"10.3389\/fimmu.2013.00069","article-title":"Natural cytotoxicity receptors: broader expression patterns and functions in innate and adaptive immune cells","volume":"4","author":"Hudspeth","year":"2013","journal-title":"Front Immunol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/j.immuni.2013.02.010","article-title":"Intraepithelial type 1 innate lymphoid cells are a unique subset of IL-12- and IL-15-responsive IFN-gamma-producing cells","volume":"38","author":"Fuchs","year":"2013","journal-title":"Immunity."},{"key":"B19","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.immuni.2016.11.005","article-title":"Human innate lymphoid cell subsets possess tissue-type based heterogeneity in phenotype and frequency","volume":"46","author":"Simoni","year":"2017","journal-title":"Immunity."},{"key":"B20","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1038\/mi.2014.63","article-title":"Identification of diverse innate lymphoid cells in human decidua","volume":"8","author":"Vacca","year":"2015","journal-title":"Mucosal Immunol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1038\/nature07537","article-title":"A human natural killer cell subset provides an innate source of IL-22 for mucosal immunity","volume":"457","author":"Cella","year":"2009","journal-title":"Nature."},{"key":"B22","doi-asserted-by":"publisher","first-page":"188","DOI":"10.3389\/fimmu.2016.00188","article-title":"NK cells and other innate lymphoid cells in hematopoietic stem cell transplantation","volume":"7","author":"Vacca","year":"2016","journal-title":"Front Immunol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"2076","DOI":"10.1182\/blood-2004-12-4802","article-title":"Paradoxic inhibition of human natural interferon-producing cells by the activating receptor NKp44","volume":"106","author":"Fuchs","year":"2005","journal-title":"Blood."},{"key":"B24","doi-asserted-by":"publisher","first-page":"e15080","DOI":"10.1371\/journal.pone.0015080","article-title":"The immune inhibitory receptor LAIR-1 is highly expressed by plasmacytoid dendritic cells and acts complementary with NKp44 to control IFNalpha production","volume":"5","author":"Bonaccorsi","year":"2010","journal-title":"PLoS ONE."},{"key":"B25","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.it.2013.01.003","article-title":"Activating natural cytotoxicity receptors of natural killer cells in cancer and infection","volume":"34","author":"Koch","year":"2013","journal-title":"Trends Immunol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1038\/icb.2013.98","article-title":"Natural cytotoxicity receptors and their ligands","volume":"92","author":"Kruse","year":"2014","journal-title":"Immunol Cell Biol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"31","DOI":"10.3389\/fimmu.2015.00031","article-title":"NKp44 and natural cytotoxicity receptors as damage-associated molecular pattern recognition receptors","volume":"6","author":"Horton","year":"2015","journal-title":"Front Immunol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1016\/j.cell.2017.11.037","article-title":"Natural killer cells control tumor growth by sensing a growth factor","volume":"172","author":"Barrow","year":"2018","journal-title":"Cell."},{"key":"B29","doi-asserted-by":"publisher","first-page":"e1470730","DOI":"10.1080\/2162402X.2018.1470730","article-title":"Nidogen-1 is a novel extracellular ligand for the NKp44 activating receptor","volume":"7","author":"Gaggero","year":"2018","journal-title":"Oncoimmunology."},{"key":"B30","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1016\/S0969-2126(03)00095-9","article-title":"The three-dimensional structure of the human NK cell receptor NKp44, a triggering partner in natural cytotoxicity","volume":"11","author":"Cantoni","year":"2003","journal-title":"Structure."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1002\/eji.200425932","article-title":"KARAP\/DAP12\/TYROBP: three names and a multiplicity of biological functions","volume":"35","author":"Tomasello","year":"2005","journal-title":"Eur J Immunol."},{"key":"B32","doi-asserted-by":"crossref","first-page":"5083","DOI":"10.4049\/jimmunol.158.11.5083","article-title":"Human killer cell activatory receptors for MHC class I molecules are included in a multimeric complex expressed by natural killer cells","volume":"158","author":"Olcese","year":"1997","journal-title":"J Immunol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1038\/35642","article-title":"Immunoreceptor DAP12 bearing a tyrosine-based activation motif is involved in activating NK cells","volume":"391","author":"Lanier","year":"1998","journal-title":"Nature."},{"key":"B34","doi-asserted-by":"publisher","first-page":"899","DOI":"10.4049\/jimmunol.172.2.899","article-title":"NKp44 triggers NK cell activation through DAP12 association that is not influenced by a putative cytoplasmic inhibitory sequence","volume":"172","author":"Campbell","year":"2004","journal-title":"J Immunol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"369","DOI":"10.3389\/fimmu.2017.00369","article-title":"Regulation of the functions of natural cytotoxicity receptors by interactions with diverse ligands and alterations in splice variant expression","volume":"8","author":"Pazina","year":"2017","journal-title":"Front Immunol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"32933","DOI":"10.18632\/oncotarget.8782","article-title":"Survival in acute myeloid leukemia is associated with NKp44 splice variants","volume":"7","author":"Shemesh","year":"2016","journal-title":"Oncotarget."},{"key":"B37","doi-asserted-by":"publisher","first-page":"10183","DOI":"10.1038\/ncomms10183","article-title":"Natural cytotoxicity receptor splice variants orchestrate the distinct functions of human natural killer cell subtypes","volume":"6","author":"Siewiera","year":"2015","journal-title":"Nat Commun."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.3389\/fimmu.2018.01897","article-title":"Human innate lymphoid cells: their functional and cellular interactions in decidua","volume":"9","author":"Vacca","year":"2018","journal-title":"Front Immunol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"8280","DOI":"10.1038\/ncomms9280","article-title":"NCR(+)ILC3 concentrate in human lung cancer and associate with intratumoral lymphoid structures","volume":"6","author":"Carrega","year":"2015","journal-title":"Nat Commun."},{"key":"B40","doi-asserted-by":"publisher","first-page":"3805","DOI":"10.4049\/jimmunol.1301889","article-title":"CD56(bright)perforin(low) noncytotoxic human NK cells are abundant in both healthy and neoplastic solid tissues and recirculate to secondary lymphoid organs via afferent lymph","volume":"192","author":"Carrega","year":"2014","journal-title":"J Immunol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"2358","DOI":"10.3389\/fimmu.2018.02358","article-title":"Hypoxia modifies the transcriptome of human NK cells, modulates their immunoregulatory profile, and influences NK cell subset migration","volume":"9","author":"Parodi","year":"2018","journal-title":"Front Immunol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"2756","DOI":"10.1002\/eji.201343448","article-title":"Hypoxia downregulates the expression of activating receptors involved in NK-cell-mediated target cell killing without affecting ADCC","volume":"43","author":"Balsamo","year":"2013","journal-title":"Eur J Immunol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.3389\/fimmu.2018.01859","article-title":"Prostaglandin E2 secreted by thyroid cancer cells contributes to immune escape through the suppression of natural killer (NK) cell cytotoxicity and NK cell differentiation","volume":"9","author":"Park","year":"2018","journal-title":"Front Immunol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1182\/blood-2007-02-074997","article-title":"Mesenchymal stem cells inhibit natural killer-cell proliferation, cytotoxicity, and cytokine production: role of indoleamine 2,3-dioxygenase and prostaglandin E2","volume":"111","author":"Spaggiari","year":"2008","journal-title":"Blood."},{"key":"B45","doi-asserted-by":"publisher","first-page":"20847","DOI":"10.1073\/pnas.0906481106","article-title":"Melanoma-associated fibroblasts modulate NK cell phenotype and antitumor cytotoxicity","volume":"106","author":"Balsamo","year":"2009","journal-title":"Proc Natl Acad Sci USA."},{"key":"B46","doi-asserted-by":"publisher","first-page":"4120","DOI":"10.1073\/pnas.0730640100","article-title":"Transforming growth factor beta 1 inhibits expression of NKp30 and NKG2D receptors: consequences for the NK-mediated killing of dendritic cells","volume":"100","author":"Castriconi","year":"2003","journal-title":"Proc Natl Acad Sci USA."},{"key":"B47","doi-asserted-by":"publisher","first-page":"3913","DOI":"10.1158\/0008-5472.CAN-17-1891","article-title":"NK-cell editing mediates epithelial-to-mesenchymal transition via phenotypic and proteomic changes in melanoma cell lines","volume":"78","author":"Huergo-Zapico","year":"2018","journal-title":"Cancer Res."},{"key":"B48","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1016\/S0198-8859(00)00201-9","article-title":"Triggering receptors involved in natural killer cell-mediated cytotoxicity against choriocarcinoma cell lines","volume":"61","author":"Sivori","year":"2000","journal-title":"Hum Immunol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"e1339","DOI":"10.1371\/journal.pone.0001339","article-title":"Expression analysis of the ligands for the Natural Killer cell receptors NKp30 and NKp44","volume":"2","author":"Byrd","year":"2007","journal-title":"PLoS ONE."},{"key":"B50","doi-asserted-by":"publisher","first-page":"10981","DOI":"10.1073\/pnas.0504315102","article-title":"NK cytotoxicity against CD4+ T cells during HIV-1 infection: a gp41 peptide induces the expression of an NKp44 ligand","volume":"102","author":"Vieillard","year":"2005","journal-title":"Proc Natl Acad Sci USA."},{"key":"B51","doi-asserted-by":"publisher","first-page":"2935","DOI":"10.1182\/blood-2013-03-489054","article-title":"Identification of a cellular ligand for the natural cytotoxicity receptor NKp44","volume":"122","author":"Baychelier","year":"2013","journal-title":"Blood."},{"key":"B52","doi-asserted-by":"publisher","first-page":"572","DOI":"10.4161\/onci.19366","article-title":"A novel mechanism for cancer cells to evade immune attack by NK cells: The interaction between NKp44 and proliferating cell nuclear antigen","volume":"1","author":"Rosental","year":"2012","journal-title":"Oncoimmunology."},{"key":"B53","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1042\/BST0370605","article-title":"PCNA on the crossroad of cancer","volume":"37","author":"Stoimenov","year":"2009","journal-title":"Biochem Soc Trans."},{"key":"B54","doi-asserted-by":"publisher","first-page":"e59552","DOI":"10.1371\/journal.pone.0059552","article-title":"Novel interaction between proliferating cell nuclear antigen and HLA I on the surface of tumor cells inhibits NK cell function through NKp44","volume":"8","author":"Horton","year":"2013","journal-title":"PLoS ONE."},{"key":"B55","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.3389\/fimmu.2018.01114","article-title":"NKp44-derived peptide binds proliferating cell nuclear antigen and mediates tumor cell death","volume":"9","author":"Shemesh","year":"2018","journal-title":"Front Immunol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1021\/pr800747c","article-title":"Natural cytotoxicity receptors NKp30, NKp44 and NKp46 bind to different heparan sulfate\/heparin sequences","volume":"8","author":"Hecht","year":"2009","journal-title":"J Proteome Res."},{"key":"B57","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/S0962-8924(00)01897-3","article-title":"Heparan sulfate: decoding a dynamic multifunctional cell regulator","volume":"11","author":"Turnbull","year":"2001","journal-title":"Trends Cell Biol."},{"key":"B58","doi-asserted-by":"publisher","first-page":"7426","DOI":"10.1021\/bi7000455","article-title":"Characterization of the recognition of tumor cells by the natural cytotoxicity receptor, NKp44","volume":"46","author":"Hershkovitz","year":"2007","journal-title":"Biochemistry."},{"key":"B59","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1054\/bjoc.2001.2054","article-title":"Heparan sulfate proteoglycans and cancer","volume":"85","author":"Blackhall","year":"2001","journal-title":"Br J Cancer."},{"key":"B60","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1002\/eji.201445177","article-title":"Regulation of natural cytotoxicity receptors by heparan sulfate proteoglycans in -cis: A lesson from NKp44","volume":"45","author":"Brusilovsky","year":"2015","journal-title":"Eur J Immunol."},{"key":"B61","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1248\/bpb.b18-00312","article-title":"Globo-A binds to the recombinant natural cytotoxicity receptor NKp44","volume":"41","author":"Ito","year":"2018","journal-title":"Biol Pharm Bull."},{"key":"B62","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/0014-5793(85)80213-1","article-title":"Structural characterization of a blood group A heptaglycosylceramide with globo-series structure. The major glycolipid based blood group A antigen of human kidney","volume":"179","author":"Breimer","year":"1985","journal-title":"FEBS Lett."},{"key":"B63","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1038\/35059110","article-title":"Recognition of haemagglutinins on virus-infected cells by NKp46 activates lysis by human NK cells","volume":"409","author":"Mandelboim","year":"2001","journal-title":"Nature."},{"key":"B64","doi-asserted-by":"publisher","first-page":"2680","DOI":"10.1002\/1521-4141(200109)31:9<2680::AID-IMMU2680>3.0.CO;2-A","article-title":"Recognition of viral hemagglutinins by NKp44 but not by NKp30","volume":"31","author":"Arnon","year":"2001","journal-title":"Eur J Immunol."},{"key":"B65","doi-asserted-by":"publisher","first-page":"2028","DOI":"10.1128\/JVI.02065-07","article-title":"H5-type influenza virus hemagglutinin is functionally recognized by the natural killer-activating receptor NKp44","volume":"82","author":"Ho","year":"2008","journal-title":"J Virol."},{"key":"B66","doi-asserted-by":"publisher","first-page":"8108","DOI":"10.1128\/JVI.00211-09","article-title":"Activation of natural killer cells by newcastle disease virus hemagglutinin-neuraminidase","volume":"83","author":"Jarahian","year":"2009","journal-title":"J Virol."},{"key":"B67","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1099\/jgv.0.001070","article-title":"Haemagglutinin-neuraminidase from HPIV3 mediates human NK regulation of T cell proliferation via NKp44 and NKp46","volume":"99","author":"McQuaid","year":"2018","journal-title":"J Gen Virol."},{"key":"B68","doi-asserted-by":"publisher","first-page":"2610","DOI":"10.4049\/jimmunol.0802806","article-title":"NKp44 receptor mediates interaction of the envelope glycoproteins from the West Nile and dengue viruses with NK cells","volume":"183","author":"Hershkovitz","year":"2009","journal-title":"J Immunol."},{"key":"B69","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1097\/QAD.0b013e3282f35551","article-title":"CCR5 or CXCR4 use influences the relationship between CD4 cell depletion, NKp44L expression and NK cytotoxicity in SHIV-infected macaques","volume":"22","author":"Vieillard","year":"2008","journal-title":"AIDS."},{"key":"B70","doi-asserted-by":"publisher","first-page":"2225","DOI":"10.1128\/JVI.80.5.2225-2233.2006","article-title":"Recognition of vaccinia virus-infected cells by human natural killer cells depends on natural cytotoxicity receptors","volume":"80","author":"Chisholm","year":"2006","journal-title":"J Virol."},{"key":"B71","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1086\/512862","article-title":"Expression of ICP0 is sufficient to trigger natural killer cell recognition of herpes simplex virus-infected cells by natural cytotoxicity receptors","volume":"195","author":"Chisholm","year":"2007","journal-title":"J Infect Dis."},{"key":"B72","doi-asserted-by":"publisher","first-page":"e0193008","DOI":"10.1371\/journal.pone.0193008","article-title":"A novel ligand on astrocytes interacts with natural cytotoxicity receptor NKp44 regulating immune response mediated by NK cells","volume":"13","author":"Bowen","year":"2018","journal-title":"PLoS ONE."},{"key":"B73","doi-asserted-by":"publisher","first-page":"8693","DOI":"10.1128\/JVI.00252-12","article-title":"Kaposi's sarcoma-associated herpesvirus ORF54\/dUTPase downregulates a ligand for the NK activating receptor NKp44","volume":"86","author":"Madrid","year":"2012","journal-title":"J Virol."},{"key":"B74","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1016\/j.celrep.2013.03.034","article-title":"Neuraminidase-mediated, NKp46-dependent immune-evasion mechanism of influenza viruses","volume":"3","author":"Bar-On","year":"2013","journal-title":"Cell Rep."},{"key":"B75","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1093\/infdis\/jiu094","article-title":"Influenza virus uses its neuraminidase protein to evade the recognition of two activating NK cell receptors","volume":"210","author":"Bar-On","year":"2014","journal-title":"J Infect Dis."},{"key":"B76","doi-asserted-by":"publisher","first-page":"2171","DOI":"10.1002\/eji.201545598","article-title":"Group 3 innate lymphoid cells (ILC3s): Origin, differentiation, and plasticity in humans and mice","volume":"45","author":"Montaldo","year":"2015","journal-title":"Eur J Immunol."},{"key":"B77","doi-asserted-by":"publisher","first-page":"72","DOI":"10.3389\/fimmu.2012.00072","article-title":"Functional differences between human NKp44(-) and NKp44(+) RORC(+) innate lymphoid cells","volume":"3","author":"Hoorweg","year":"2012","journal-title":"Front Immunol."},{"key":"B78","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1016\/j.immuni.2013.05.013","article-title":"RORgammat(+) innate lymphoid cells acquire a proinflammatory program upon engagement of the activating receptor NKp44","volume":"38","author":"Glatzer","year":"2013","journal-title":"Immunity."},{"key":"B79","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1038\/jid.2013.477","article-title":"Characterization of innate lymphoid cells in human skin and blood demonstrates increase of NKp44+ ILC3 in psoriasis","volume":"134","author":"Villanova","year":"2014","journal-title":"J Invest Dermatol."},{"key":"B80","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1016\/j.celrep.2017.09.070","article-title":"Cross-tissue transcriptomic analysis of human secondary lymphoid organ-residing ILC3s reveals a quiescent state in the absence of inflammation","volume":"21","author":"Bar-Ephraim","year":"2017","journal-title":"Cell Rep."},{"key":"B81","doi-asserted-by":"publisher","first-page":"e1003257","DOI":"10.1371\/journal.ppat.1003257","article-title":"Human cytomegalovirus infection elicits new decidual natural killer cell effector functions","volume":"9","author":"Siewiera","year":"2013","journal-title":"PLoS Pathog."},{"key":"B82","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1038\/nm1452","article-title":"Decidual NK cells regulate key developmental processes at the human fetal-maternal interface","volume":"12","author":"Hanna","year":"2006","journal-title":"Nat Med."},{"key":"B83","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1007\/s00418-006-0160-y","article-title":"Location of cell cycle regulators cyclin B1, cyclin A, PCNA, Ki67 and cell cycle inhibitors p21, p27 and p57 in human first trimester placenta and deciduas","volume":"125","author":"Korgun","year":"2006","journal-title":"Histochem Cell Biol."},{"key":"B84","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.it.2018.02.002","article-title":"Natural killer cells detect a tumor-produced growth factor: a vestige of antiviral resistance?","volume":"39","author":"Trinchieri","year":"2018","journal-title":"Trends Immunol."},{"key":"B85","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/S1359-6101(02)00090-4","article-title":"Novel PDGF family members: PDGF-C and PDGF-D","volume":"14","author":"Li","year":"2003","journal-title":"Cytokine Growth Factor Rev."},{"key":"B86","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1038\/35074588","article-title":"PDGF-D is a specific, protease-activated ligand for the PDGF beta-receptor","volume":"3","author":"Bergsten","year":"2001","journal-title":"Nat Cell Biol."},{"key":"B87","doi-asserted-by":"publisher","first-page":"5723","DOI":"10.1111\/j.1742-4658.2005.04989.x","article-title":"Structural and functional specificities of PDGF-C and PDGF-D, the novel members of the platelet-derived growth factors family","volume":"272","author":"Reigstad","year":"2005","journal-title":"FEBS J."},{"key":"B88","first-page":"3729","article-title":"Platelet-derived growth factor (PDGF) autocrine signaling regulates survival and mitogenic pathways in glioblastoma cells: evidence that the novel PDGF-C and PDGF-D ligands may play a role in the development of brain tumors","volume":"62","author":"Lokker","year":"2002","journal-title":"Cancer Res."},{"key":"B89","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.bbcan.2010.04.003","article-title":"Emerging roles of PDGF-D signaling pathway in tumor development and progression","volume":"1806","author":"Wang","year":"2010","journal-title":"Biochim Biophys Acta."},{"key":"B90","doi-asserted-by":"publisher","first-page":"eaam9628","DOI":"10.1126\/sciimmunol.aam9628","article-title":"Complement factor P is a ligand for the natural killer cell-activating receptor NKp46","volume":"2","author":"Narni-Mancinelli","year":"2017","journal-title":"Sci Immunol."},{"key":"B91","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1146\/annurev-immunol-032712-095951","article-title":"Regulation of ligands for the NKG2D activating receptor","volume":"31","author":"Raulet","year":"2013","journal-title":"Annu Rev Immunol."},{"key":"B92","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1158\/2326-6066.CIR-15-0098","article-title":"NKG2D receptor and its ligands in host defense","volume":"3","author":"Lanier","year":"2015","journal-title":"Cancer Immunol Res."},{"key":"B93","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/S0006-291X(03)01560-2","article-title":"Identification of secreted CD155 isoforms","volume":"309","author":"Baury","year":"2003","journal-title":"Biochem Biophys Res Commun."},{"key":"B94","doi-asserted-by":"publisher","first-page":"e0152982","DOI":"10.1371\/journal.pone.0152982","article-title":"Increased soluble CD155 in the serum of cancer patients","volume":"11","author":"Iguchi-Manaka","year":"2016","journal-title":"PLoS ONE."},{"key":"B95","doi-asserted-by":"publisher","first-page":"3429","DOI":"10.1158\/0008-5472.CAN-13-3017","article-title":"Metalloprotease-mediated tumor cell shedding of B7-H6, the ligand of the natural killer cell-activating receptor NKp30","volume":"74","author":"Schlecker","year":"2014","journal-title":"Cancer Res."},{"key":"B96","doi-asserted-by":"publisher","first-page":"e1001224","DOI":"10.1080\/2162402X.2014.1001224","article-title":"B7-H6-mediated downregulation of NKp30 in NK cells contributes to ovarian carcinoma immune escape","volume":"4","author":"Pesce","year":"2015","journal-title":"Oncoimmunology."},{"key":"B97","doi-asserted-by":"publisher","first-page":"3658","DOI":"10.1182\/blood-2013-01-476606","article-title":"Soluble ligands for NK cell receptors promote evasion of chronic lymphocytic leukemia cells from NK cell anti-tumor activity","volume":"121","author":"Reiners","year":"2013","journal-title":"Blood."},{"key":"B98","doi-asserted-by":"publisher","first-page":"2879","DOI":"10.1007\/s00018-010-0367-x","article-title":"Basement membrane components are key players in specialized extracellular matrices","volume":"67","author":"Kruegel","year":"2010","journal-title":"Cell Mol Life Sci."},{"key":"B99","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.matbio.2016.12.009","article-title":"The nature and biology of basement membranes","volume":"58","author":"Pozzi","year":"2017","journal-title":"Matrix Biol."},{"key":"B100","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1093\/jjco\/hyu187","article-title":"Nidogen-1: a candidate biomarker for ovarian serous cancer","volume":"45","author":"Li","year":"2015","journal-title":"Jpn J Clin Oncol."},{"key":"B101","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.neo.2017.01.008","article-title":"Nidogen-1 degraded by cathepsin S can be quantified in serum and is associated with non-small cell lung cancer","volume":"19","author":"Willumsen","year":"2017","journal-title":"Neoplasia."},{"key":"B102","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1101\/gad.301937.117","article-title":"Identification of Nidogen 1 as a lung metastasis protein through secretome analysis","volume":"31","author":"Aleckovic","year":"2017","journal-title":"Genes Dev."},{"key":"B103","doi-asserted-by":"publisher","first-page":"e43494","DOI":"10.1371\/journal.pone.0043494","article-title":"Cleavage of nidogen-1 by cathepsin S impairs its binding to basement membrane partners","volume":"7","author":"Sage","year":"2012","journal-title":"PLoS ONE."},{"key":"B104","doi-asserted-by":"publisher","first-page":"2315","DOI":"10.1002\/ijc.28271","article-title":"Contribution of ADAMTS1 as a tumor suppressor gene in human breast carcinoma. Linking its tumor inhibitory properties to its proteolytic activity on nidogen-1 and nidogen-2","volume":"133","author":"Martino-Echarri","year":"2013","journal-title":"Int Jo Cancer."},{"key":"B105","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.cellimm.2013.08.005","article-title":"Constitutive expression of ligand for natural killer cell NKp44 receptor (NKp44L) by normal human articular chondrocytes","volume":"285","author":"Bialoszewska","year":"2013","journal-title":"Cell Immunol."},{"key":"B106","doi-asserted-by":"publisher","first-page":"2075","DOI":"10.4049\/jimmunol.1100433","article-title":"Multiple receptors trigger human NK cell-mediated cytotoxicity against porcine chondrocytes","volume":"188","author":"Sommaggio","year":"2012","journal-title":"J Immunol."},{"key":"B107","first-page":"2468","article-title":"Platelet-derived growth factor D: tumorigenicity in mice and dysregulated expression in human cancer","volume":"62","author":"LaRochelle","year":"2002","journal-title":"Cancer Res."}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.00719\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,15]],"date-time":"2023-09-15T14:38:22Z","timestamp":1694788702000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.00719\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,9]]},"references-count":107,"alternative-id":["10.3389\/fimmu.2019.00719"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2019.00719","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,9]]},"article-number":"719"}}